ATE81288T1 - Verkapselung von trh bzw. dessen analoga. - Google Patents

Verkapselung von trh bzw. dessen analoga.

Info

Publication number
ATE81288T1
ATE81288T1 AT87306794T AT87306794T ATE81288T1 AT E81288 T1 ATE81288 T1 AT E81288T1 AT 87306794 T AT87306794 T AT 87306794T AT 87306794 T AT87306794 T AT 87306794T AT E81288 T1 ATE81288 T1 AT E81288T1
Authority
AT
Austria
Prior art keywords
trh
analogs
encapsulation
active ingredient
release
Prior art date
Application number
AT87306794T
Other languages
English (en)
Inventor
Toshiro Heya
Hiroaki Okada
Yasuaki - Koaza-Tanita Ogawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE81288T1 publication Critical patent/ATE81288T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Networks Using Active Elements (AREA)
  • Amplifiers (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87306794T 1986-08-08 1987-07-31 Verkapselung von trh bzw. dessen analoga. ATE81288T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18746786 1986-08-08
EP87306794A EP0256726B1 (de) 1986-08-08 1987-07-31 Verkapselung von TRH bzw. dessen Analoga

Publications (1)

Publication Number Publication Date
ATE81288T1 true ATE81288T1 (de) 1992-10-15

Family

ID=16206591

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87306794T ATE81288T1 (de) 1986-08-08 1987-07-31 Verkapselung von trh bzw. dessen analoga.

Country Status (7)

Country Link
US (1) US5652220A (de)
EP (1) EP0256726B1 (de)
JP (1) JP2526589B2 (de)
KR (1) KR880002514A (de)
AT (1) ATE81288T1 (de)
CA (1) CA1300011C (de)
DE (1) DE3782117T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
DE69025272T2 (de) * 1989-11-17 1996-06-27 Takeda Chemical Industries Ltd Therapeutisches Mittel für Erkrankungen des Zentralnervensystems
JP2653255B2 (ja) * 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
MY107937A (en) * 1990-02-13 1996-06-29 Takeda Chemical Industries Ltd Prolonged release microcapsules.
JPH04124127A (ja) * 1990-09-14 1992-04-24 Chugai Pharmaceut Co Ltd マイクロカプセル型徐放性製剤及びその製造法
ZA918168B (en) * 1990-10-16 1993-04-14 Takeda Chemical Industries Ltd Prolonged release preparation and polymers thereof.
JP3698721B2 (ja) * 1993-02-23 2005-09-21 ジェネンテク・インコーポレイテッド 有機溶媒を用いて処理したポリペプチドの賦形剤安定化
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6149953A (en) * 1993-11-08 2000-11-21 Delta Food Group, Inc. Seeded microcapsules
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
US6303134B1 (en) 1996-08-29 2001-10-16 Advanced Research And Technology Institute, Inc. Pharmacotherapeutic process and composition for central nervous system disorders
CA2406846C (en) 2000-04-21 2008-11-18 Advanced Research And Technology Institute, Inc. Pharmacotherapeutic process and composition for central nervous system disorders
DE10025948A1 (de) * 2000-05-26 2001-11-29 Gruenenthal Gmbh Wirkstoffkombination
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
FR2867075B1 (fr) * 2004-03-03 2006-07-14 Ethypharm Sa Procede de preparation de microspheres biodegradables calibrees
US20080305175A1 (en) * 2006-11-30 2008-12-11 Agency For Science, Technology And Research Micro-Container

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792550A (nl) * 1971-12-23 1973-06-12 Agfa Gevaert Nv Procede voor het vervaardigen van microcapsules
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
JPS60125245A (ja) * 1983-12-12 1985-07-04 Nitto Electric Ind Co Ltd 液状活性物質含有マイクロカプセルの製造方法
EP0190833B1 (de) * 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Verfahren zur Herstellung von Mikrokapseln

Also Published As

Publication number Publication date
DE3782117D1 (de) 1992-11-12
KR880002514A (ko) 1988-05-09
EP0256726A2 (de) 1988-02-24
JP2526589B2 (ja) 1996-08-21
US5652220A (en) 1997-07-29
JPS63233926A (ja) 1988-09-29
EP0256726A3 (en) 1988-04-20
CA1300011C (en) 1992-05-05
DE3782117T2 (de) 1993-03-11
EP0256726B1 (de) 1992-10-07

Similar Documents

Publication Publication Date Title
DE3782117D1 (de) Verkapselung von trh bzw. dessen analoga.
EP0184942A3 (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
EP0350246A3 (en) Sustained release microcapsule for water soluble drug
DE3751811D1 (de) LH-RH-Analoga enthaltende Formulierungen
ZA845541B (en) Aqueous solution containing lipid-soluble pharmaceutical substance
DE2967573D1 (en) Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
EP0186071A3 (en) Transdermal system for timolol
GB2192131B (en) Pharmaceutical compositions containing calcium salts.
GR3006426T3 (de)
GR3004959T3 (de)
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
HUT47793A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
ATE115579T1 (de) Imidazolsulfonamid-derivate, herbizide und verfahren zur bekämpfung von schadpflanzen.
ATE81000T1 (de) Stabilisierte, n-acetylcysteinhaltige arzneimittelzubereitung.
HUT47792A (en) Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components
PT80961A (en) Process for the preparation of new pharmaceutical compounds containing mixtures of 4,9-dihydro-4-(1-methyl-4-piperydilene)-10h-benzoý4,5¨-cycloheptaý1,2-b¨thyophene-10-one and antiasthmati c xantines as active ingredient
JPS6420261A (en) Aqueous composition containing polymerized fatty acid polyamide
ATE20230T1 (de) Spasmolytisch wirksames (+)s-enantiomer von secoverin.
NO164599C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.
EG12070A (en) Agent for regulating plant growth containing as active ingredient 2-cyano-bicyclo(2,2,1)heptane
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
ATE81002T1 (de) Fixe arzneimittelkombination mit verzoegerter freisetzung.
DE3360845D1 (en) Immunomodulators containing as the active ingredient alpha-benzyl malic acid
HUT45854A (en) Selective fungicides comprising asymmetrical 2-pyridyl-phosphoric acid esters as active ingredient

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties